Wall Street''s main regulator on Thursday voted to adopt a measure requiring that U.S.-listed companies disclose how the pay of their top executives squares with overall company performance.
![]()
| View Original |
After staying on the sidelines for much of the pandemic, activist investors are once again campaigning against companies and Boards. Why they’re back, and what to do about them.
![]()
| View Original |
The Canada Business Corporations Act (CBCA) will be amended effective August 31, 2022 (Amendments) to require shareholders of a public company governed by such legislation to vote "for" or "against" directors at annual meetings of shareholders. This is a departure from the "for" and "withhold" options previously offered to CBCA public company shareholders. Subject to certain exceptions, the Amendments also contemplate that each director in an uncontested election (i.e., where the number of director nominees is equal to the number of directors positions to be filled) must receive more "for" votes than "against" votes to be elected.
![]()
| View Original |
Lynn Strongin Dodds looks at why independent research providers (IRP) have not gained the foothold expected after MiFID II.
![]()
| View Original |
Corporate America's leading business groups are taking the SEC to court after it undid two-year-old rules around proxy advisers.
![]()
| View Original |
Given stock markets’ unprecedented performance during the pandemic years of 2020 and 2021, 2022 should have been even better with recovery from the pandemic and reopening of businesses. But the stock market performance has been exactly the opposite. A few firms losing 60% or more of their value is not an unusual thing - it happens regularly. And it can happen en masse like during the dotcom bust in 2000. What’s unusual about today’s situation is that some of the current orphan stocks - those that have lost more than 90% of their recent stock price peaks - remain market leaders and their products continue to have mass appeal.
![]()
| View Original |